Sotera Health Co

Healthcare · Diagnostics & Research

17.80$ -0.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Sotera Health Co (SHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 321 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement SHC
Line item	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	195	195	195	193	188	213	200	217	212	252	226	241	237	267	249	252	221	255	263	310	248	277	285	290	255	294	311	303	280	321	1,216
Cost of Revenue	96	96	95	96	92	94	93	96	97	108	101	107	108	116	113	110	109	116	117	130	121	124	127	126	119	128	134	138	136	143	551
Gross Profit	99	99	100	97	97	119	108	121	115	144	126	134	129	150	136	142	112	140	146	180	127	153	158	164	135	167	178	166	144	178	665
Selling, General & Administrative	–	–	44	37	37	43	46	53	53	50	44	52	60	63	57	66	62	60	54	60	58	61	62	62	63	69	63	58	68	68	257
Total Operating Expenses	46	46	59	52	52	57	60	68	69	65	60	68	75	79	73	82	78	76	70	76	74	76	78	77	78	78	66	30	57	71	225
Operating Income	52	52	36	45	45	62	47	52	46	78	66	66	53	71	63	60	33	63	76	104	53	77	81	87	57	88	111	136	87	107	441
Interest Expense	–	–	39	43	57	55	55	48	21	19	18	16	10	14	23	32	29	31	41	43	42	40	42	41	41	41	39	35	35	34	143
Pre-Tax Income	16	16	-12	-21	-14	11	-0.6	-35	14	62	41	59	45	48	42	-379	5.4	34	0.5	66	11	15	43	45	-15	19	73	70	43	78	264
Income Tax Expense	9.3	9.3	-6.0	6.9	-12	3.8	-1.2	8.3	3.0	19	14	23	15	18	17	-59	2.6	11	14	27	4.7	6.4	26	33	-1.6	11	25	36	16	24	101
Net Income	6.3	6.3	-5.6	-28	-2.0	7.0	0.0	-44	11	43	27	36	31	30	25	-320	2.8	24	-14	39	6.3	8.8	17	12	-13	8.0	48	35	27	54	163
EBITDA	90	90	64	59	78	101	91	49	73	118	97	112	92	99	102	-310	74	105	79	149	93	95	127	126	67	95	140	138	108	146	533

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings